SCHEMBL29475124

SCHEMBL29475124

CCOC(=O)c1cc2cc([C@H]3CCOC(C)(C)C3)ccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ HPGD P15428 3/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ MMP13 P45452 8/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ HRH3 Q9Y5N1 1/20 0.50
▸ MMP2 P08253 6/20 0.49
▸ MMP14 P50281 4/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ ATM Q13315 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29475141 1.00 RAB9A (0.53) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21175334 1.00 RAB9A (0.53) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL25025323 1.00 RAB9A (0.53) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21175271 1.00 RAB9A (0.53) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31263051 0.89 XDH (0.44) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL29475138 0.85 PIN1 (0.46) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20014763 0.85 PIN1 (0.46) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL23732403 0.85 RAB9A (0.60) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL30140652 0.85 RAB9A (0.60) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL21355515 0.83 RAB9A (0.67) RAB9AKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026097750-A1 METHOD FOR SYNTHESIZING ARYL-SUBSTITUTED CHIRAL TETRAHYDROPYRAN RING BY MEANS OF DE-SYMMETRIZATION 杭州澳赛诺生物科技有限公司 2026-05-15 — — WO disclosed
CN-120136870-A GLP-1 receptor targeting compounds and uses thereof 信达生物科技有限公司 2025-06-13 — — CN disclosed
CN-119101040-B Method for synthesizing aryl substituted chiral tetrahydropyran ring through desymmetrical synthesis 杭州澳赛诺医药技术有限公司 2025-03-21 — — CN disclosed
CN-119431365-A Phenyl heterocyclic derivative-containing regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2025-02-14 — — CN disclosed
WO-2025026270-A1 BENZO NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2025-02-06 — — WO disclosed
CN-119101040-A Method for synthesizing aryl substituted chiral tetrahydropyran ring through desymmetrical synthesis 杭州澳赛诺医药技术有限公司 2024-12-10 — — CN disclosed
CN-109790161-B Pyrazolopyridine derivatives having GLP-1 receptor agonist action 中外制药株式会社 2022-03-11 — — CN disclosed
Send feedback